Pancreatic Cancer Research

ResearcherCalifornia NanoSystems InstituteNo recent work listed

Ying Chao Ji

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8850-2184; OpenAlex author ID A5033499563. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2020: 1 paper · 2021: 2 papers

Papers 3

  1. Combination Chemo-Immunotherapy for Pancreatic Cancer Using the Immunogenic Effects of an Irinotecan Silicasome Nanocarrier Plus Anti-PD-1. Co-author DOI 10.1002/advs.202002147↗
  2. Development of Facile and Versatile Platinum Drug Delivering Silicasome Nanocarriers for Efficient Pancreatic Cancer Chemo-Immunotherapy. Co-author DOI 10.1002/smll.202005993↗
  3. Use of ratiometrically designed nanocarrier targeting CDK4/6 and autophagy pathways for effective pancreatic cancer treatment. Co-author DOI 10.1038/s41467-020-17996-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiangsheng Liu · 3 shared papers, 2020–2021 · strength 0.34
  2. Huan Meng · 3 shared papers, 2020–2021 · strength 0.34
  3. André E. Nel · 2 shared papers, 2021 · strength 0.22
  4. Timothy R. Donahue · 1 shared paper, 2020 · strength 0.11
  5. Juan Li · 1 shared paper, 2020 · strength 0.11
  6. Zev A. Wainberg · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.